<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03909048</url>
  </required_header>
  <id_info>
    <org_study_id>300002878</org_study_id>
    <nct_id>NCT03909048</nct_id>
  </id_info>
  <brief_title>Chronic Low Back Pain Graded - Exposure Psychoeducation Intervention</brief_title>
  <acronym>VRGE</acronym>
  <official_title>Chronic Low Back Pain Graded - Exposure Psychoeducation Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effectiveness of one of two psychoeducation treatments on chronic
      low back pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will examine the effectiveness of one of two psychoeducation treatments on chronic
      low back pain. Participants will be randomized to one of these two treatments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participant, statistician, and outcomes assessor are blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity as assessed by Numeric Rating Scale</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The Numeric Rating Scale (NRS) measures pain intensity measured via 0-10 numeric rating scale.
0 = No Pain - 10 = Worst Possible Pain Range of scores: 0-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Present Pain Intensity</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>Present Pain Intensity (PPI) assesses present pain intensity on a scale of 0 (no pain) to 5 (excruciating)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Present Pain Rating</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>Pain Rating Index (PRI) is assessed by 15 questions assessing pain in the sensory and affective dimensions.
Items rate from 0 (none) to 3 (severe) on degree to which the words apply to pain.
Score Range: 0-45</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Chronicity assessed by the Graded Chronic Pain Scale</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>Pain Chronicity is assessed by the Graded Chronic Pain Scale (GCPS). The GCPS is 7 questions with 3 sub-scales (Characteristic pain intensity, disability score, and disability points).
Scoring:
Characteristic Pain Intensity: is a 0 to 100 score derived from Questions 1 through 3: Mean (Pain Right Now, Worst Pain, Average Pain) X 10.
Disability Score: is 0 to 100 score derived from Questions 4 through 6: Mean (Daily Activities, Social Activities, Work Activities) X 10 Disability Points: Add the indicated points for Disability Days (Question 7) and for Disability Score (0-6).
Items rate from 0 to 10 with 0 referencing no pain/interference/change and 10 referencing pain as bad as could be/unable to carry out any activities/extreme change.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Daily Pain Monitoring: 10 point scale</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>Daily pain monitoring defined as daily pain intensity and daily pain interference monitoring is two questions asked daily on a 10 point scale assessing daily pain and how much pain had interfered with day to day activities.
Pain: Over the past 24 hours, how would you rate your back pain on average? (0=No Pain; 10=Worst Imaginable Pain)
Interference: Over the past 24 hours, how much did pain interfere with your day-to-day activities? (0=No Interference; 10 = A great deal of interference)&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Back Disability as assessed by the Roland Morris Disability Questionnaire</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The Roland Morris Disability Questionnaire (RMDQ) assesses disability due to low back pain.
The RMDQ is a 24 item survey with yes/no response options. Score 0 -24 with ower scores indicate more impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20 item survey tool. The items are a 4 pt Likert response items.
Scores range from 0-60 with higher scores indicate greater levels of depressive symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing as assessed by the Pain Catastrophizing Scale</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) is a 13 item survey assessing catastrophizing in context to pain. There are 13 items with 5-pt Likert responses.
There are several subscales. Scoring Procedure: The PCS total score is computed by summing responses to all 13 items (0-52).
Subscales:
Rumination: Sum of items 8, 9, 10, 11 (0-16). Magnification: Sum of items 6, 7, 13 (0-12). Helplessness: Sum of items 1, 2, 3, 4, 5, 12 (0-24).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-related fear of movement as assessed by the Tampa Scale Kinesiophobia</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The Tampa Scale Kinesiophobia (TSK) is a 17 item assessment of fear of movement. This uses a 5-pt Likert scale from 1 = Strongly Disagree to 4 = Strongly Agree.
Scoring Procedure: Sum items Range: 17-68 Subscale Harm/Somatic Items: 3, 5, 6, 9, 11, 15 Subscale Avoidance Items: 1, 2, 7, 10, 13, 14, 17</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood and Affect as assessed by the Positive and Negative Affect Scale</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The Positive and Negative Affect Scale (PANAS) measures mood of participants. This is a 20 item survey with 5 pt Likert response indicating to what degree the participant feels those emotions. There is a positive and negative subscale.
Higher positive affect score indicates greater positive emotions; higher negative affect score indicates greater negative emotions.
Range of Scores: 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immersive Tendencies</measure>
    <time_frame>Baseline only</time_frame>
    <description>Immersive Tendencies are assessed by the Immersive Tendencies Questionnaire (ITQ). This is an 18-item survey. Item responses use a 7 point Likert scale. Subscales include: focus, involvement, emotions, and play. Each subscale is scored by summing items. A total score is scored by summing all items.
Range of total score: 18-126 Focus range of scores: 5-35 Involvement range of scores: 5-35 Emotions range of scores: 4-28 Play range of scores: 3-21 Higher scores indicate higher immersive tendencies overall and in each sub-scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absorption Tendencies</measure>
    <time_frame>Baseline Only</time_frame>
    <description>Tellegen Absorption Scale is a 34-item multi-dimensional measure that assesses imaginative involvement and the tendency to become mentally absorbed in everyday activities. Item responses are on a 5-point Likert scale. Items are summed to score.
Range of scores: 0-136. Higher scores indicate greater levels of absorption.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Video Game History</measure>
    <time_frame>Baseline Only</time_frame>
    <description>History of playing video games.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Treatment Evaluation as assessed by the Modified Treatment Evaluation Inventory</measure>
    <time_frame>Final assessment (average 1 week post treatment)</time_frame>
    <description>Patient treatment evaluation is assessed by Treatment Evaluation Inventory. This is a 9 item scale with a 5-point Likert responses for each question. The items are scored by summing all items.
Range of scores: 9-45. A higher score indicates greater acceptance of treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Treatment Evaluation as assessed by Semi-structured Qualitative interviewing</measure>
    <time_frame>Final assessment (average 1 week post treatment)</time_frame>
    <description>Patient treatment evaluation is assessed by semi-structured interviewing. Qualitative feedback from participant experience will be assessed by thematic analyses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily intervention feedback questions</measure>
    <time_frame>Baseline - Final assessment (average 1 week post treatment)</time_frame>
    <description>The daily intervention feedback questions are 7 items that assess the individuals feelings and experiences during that daily intervention session.
0-10 Likert scale
Each item is it's own scale.
Higher scores indicate more enjoyment/usefulness/demand/awareness/concern/mood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Treatment Evaluation as assessed by the Usefulness, Satisfaction, and Ease of Use Questionnaire</measure>
    <time_frame>Final assessment (average 1 week post treatment)</time_frame>
    <description>The Usefulness, Satisfaction, and Ease of Use Questionnaire (USE, Lund, 2001) measures the subjective usability of a product or service. It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction. This metric can be applied to various scenarios of usability assessment because it is non-proprietary and technology-agnostic. is a 30 item survey.
Each item is presented on a 7-point Likert scale from strongly disagree = 1 to strongly agree. = 7
Each subscale is calculated by averaging all items in subscale. Usefulness: items 1-8 Ease of use: items 9-19 Ease of Learning: items 20-23 Satisfaction: items 24-30
Range of scores for each subscale: 1-7 Scoring Interpretation: Higher score indicates greater usefulness, satisfaction, and ease of use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Treatment Evaluation as assessed by the Patient Global Impression of Change Scale</measure>
    <time_frame>Final assessment (average 1 week post treatment)</time_frame>
    <description>Patient treatment evaluation is assessed by the Patient Global Impression of Change. This is a one item 7 point Likert item assessing improvement of the participants overall status.
Item responses:
1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = no change, 5 = minimally worse, 6 = much worse, and 7 = very much worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Video Game Preferences as assessed by the BrainHex</measure>
    <time_frame>Final assessment (average 1 week post treatment)</time_frame>
    <description>Video game preferences will be assessed by the BrainHex. The BrainHex provides a tool for designing gameplay and understanding motivations for play.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Interactive Psycho-education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interactive psycho-education using interactive dashboard.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Psycho-education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-interactive psycho-education not using interactive dashboard.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interactive - Psychoeducation</intervention_name>
    <description>Individuals will receive interactive psychoeducation in the lab over the course of a week period. Each session will take approximately 30 minutes.</description>
    <arm_group_label>Interactive Psycho-education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Non-interactive Psychoeducation</intervention_name>
    <description>Individuals will receive non-interactive psychoeducation over the course of a week period. Each session will take approximately 30 minutes.</description>
    <arm_group_label>Psycho-education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  report having low back pain for more than three months and at least half the days in
             the past 6 months

          -  be 18-65 years of age,

          -  have scores higher than 37 on the Tampa Scale of Kinesiophobia,

        Exclusion Criteria:

          -  medical conditions other than back pain that significantly impair movement (e.g.,
             arthritis)

          -  confirmed/suspected pregnancy

          -  pending litigation related to an episode of low back pain

          -  significant impairment in vision
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>April 5, 2019</study_first_submitted>
  <study_first_submitted_qc>April 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2019</study_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Zina Trost</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Chronic Pain</keyword>
  <keyword>Low Back Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

